GynecologyNews.net

Gynecology Xagena

Xagena Mappa
Medical Meeting
Ematobase.it
XagenaNewsletter

Search results for "Lasofoxifene"

Lasofoxifene ( Fablyn ) statistically reduced the overall risk of breast cancer, as well as ER positive invasive breast cancer in postmenopausal women with low bone density.Lasofoxifene is a SERM, or ...